A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.
published in: Blood Cancer Journal
date of publication: 2015-09-25
main subject: lymphoblastic leukemia, T-cell acute lymphoblastic leukemia
Cites articles 14
- 2008-03-01
- 2007-11-01
Date
Title
Article - wd:Q43170125